News Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston Staff September 11, 2023 Iframe sync Post navigation Previous: Major shareholder announcement – BlackRock, Inc.Next: Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration More Stories Clinical Trial Healthcare News Pharmaceutical Marijuana Rescheduling Makes Strange Bedfellows: MMJ and State Operators Take Their Battles to Federal Court Staff November 21, 2026 Diagnostics EHR Healthcare immunotherapy News ModuleMD Continues to Strengthen Its Position in Allergy EHR Innovation with a New Generation of AI-Powered Technology Staff November 21, 2026 Healthcare News Pharmaceutical FlatRx Publishes a Dated Price Comparison of Compounded Tirzepatide at 27 U.S. Telehealth Programs Counted at a 10 mg Weekly Dose Staff November 21, 2026